Palonosetron and prednisolone for the prevention of nausea and emesis during fractionated radiotherapy and 5 cycles of concomitant weekly cisplatin-a phase II study.
about
Prophylactic Management of Radiation-Induced Nausea and Vomiting2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting.New treatments on the horizon for chemoradiotherapy-induced nausea and vomiting.Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists.
P2860
Palonosetron and prednisolone for the prevention of nausea and emesis during fractionated radiotherapy and 5 cycles of concomitant weekly cisplatin-a phase II study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Palonosetron and prednisolone ...... ly cisplatin-a phase II study.
@en
Palonosetron and prednisolone ...... ly cisplatin-a phase II study.
@nl
type
label
Palonosetron and prednisolone ...... ly cisplatin-a phase II study.
@en
Palonosetron and prednisolone ...... ly cisplatin-a phase II study.
@nl
prefLabel
Palonosetron and prednisolone ...... ly cisplatin-a phase II study.
@en
Palonosetron and prednisolone ...... ly cisplatin-a phase II study.
@nl
P2093
P2860
P1476
Palonosetron and prednisolone ...... kly cisplatin-a phase II study
@en
P2093
Charlotte Belli
Jørn Herrstedt
P2860
P2888
P304
P356
10.1007/S00520-013-1926-0
P577
2013-08-15T00:00:00Z